Selected research
Market Structure
Global Parenteral PrEP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Parenteral PrEP market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Parenteral PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Parenteral PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Parenteral PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Parenteral PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Parenteral PrEP include Gilead Sciences and ViiV Healthcare among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Parenteral PrEP market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Parenteral PrEP and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Parenteral PrEP sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Parenteral PrEP market size, projected growth trends, production technologies, key applications, and end-use industries.
Parenteral PrEP Segment by Company
Gilead Sciences
ViiV Healthcare
Parenteral PrEP Segment by Type
Cabotegravir
Lenacapavir
Other
Parenteral PrEP Segment by Application
Subcutaneous Use
Intramuscular Use
Parenteral PrEP Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral PrEP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parenteral PrEP and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral PrEP.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Parenteral PrEP market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parenteral PrEP manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Parenteral PrEP in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Parenteral PrEP in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cabotegravir
- Lenacapavir
- Other
Applications
- Subcutaneous Use
- Intramuscular Use
Companies covered
- Gilead Sciences
- ViiV Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Parenteral PrEP Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Parenteral PrEP Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Parenteral PrEP Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Parenteral PrEP Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Parenteral PrEP Market Dynamics
- 2.1 Parenteral PrEP Industry Trends
- 2.2 Parenteral PrEP Industry Drivers
- 2.3 Parenteral PrEP Industry Opportunities and Challenges
- 2.4 Parenteral PrEP Industry Restraints
3 Parenteral PrEP Market by Manufacturers
- 3.1 Global Parenteral PrEP Revenue by Manufacturers (2021-2026)
- 3.2 Global Parenteral PrEP Sales by Manufacturers (2021-2026)
- 3.3 Global Parenteral PrEP Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Parenteral PrEP Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Parenteral PrEP Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Parenteral PrEP Manufacturers, Product Type & Application
- 3.7 Global Parenteral PrEP Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Parenteral PrEP Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Parenteral PrEP Players Market Share by Revenue in 2025
- 3.8.3 2025 Parenteral PrEP Tier 1, Tier 2, and Tier 3
4 Parenteral PrEP Market by Type
- 4.1 Parenteral PrEP Type Introduction
- 4.1.1 Cabotegravir
- 4.1.2 Lenacapavir
- 4.1.3 Other
- 4.2 Global Parenteral PrEP Sales by Type
- 4.2.1 Global Parenteral PrEP Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Parenteral PrEP Sales by Type (2021-2032)
- 4.2.3 Global Parenteral PrEP Sales Market Share by Type (2021-2032)
- 4.3 Global Parenteral PrEP Revenue by Type
- 4.3.1 Global Parenteral PrEP Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Parenteral PrEP Revenue by Type (2021-2032)
- 4.3.3 Global Parenteral PrEP Revenue Market Share by Type (2021-2032)
5 Parenteral PrEP Market by Application
- 5.1 Parenteral PrEP Application Introduction
- 5.1.1 Subcutaneous Use
- 5.1.2 Intramuscular Use
- 5.2 Global Parenteral PrEP Sales by Application
- 5.2.1 Global Parenteral PrEP Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Parenteral PrEP Sales by Application (2021-2032)
- 5.2.3 Global Parenteral PrEP Sales Market Share by Application (2021-2032)
- 5.3 Global Parenteral PrEP Revenue by Application
- 5.3.1 Global Parenteral PrEP Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Parenteral PrEP Revenue by Application (2021-2032)
- 5.3.3 Global Parenteral PrEP Revenue Market Share by Application (2021-2032)
6 Global Parenteral PrEP Sales by Region
- 6.1 Global Parenteral PrEP Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Parenteral PrEP Sales by Region (2021-2032)
- 6.2.1 Global Parenteral PrEP Sales by Region (2021-2026)
- 6.2.2 Global Parenteral PrEP Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Parenteral PrEP Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Parenteral PrEP Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Parenteral PrEP Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Parenteral PrEP Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Parenteral PrEP Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Parenteral PrEP Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Parenteral PrEP Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Parenteral PrEP Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Parenteral PrEP Revenue by Region
- 7.1 Global Parenteral PrEP Revenue by Region
- 7.1.1 Global Parenteral PrEP Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Parenteral PrEP Revenue by Region (2021-2026)
- 7.1.3 Global Parenteral PrEP Revenue by Region (2027-2032)
- 7.1.4 Global Parenteral PrEP Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Parenteral PrEP Revenue (2021-2032)
- 7.2.2 North America Parenteral PrEP Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Parenteral PrEP Revenue (2021-2032)
- 7.3.2 Europe Parenteral PrEP Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Parenteral PrEP Revenue (2021-2032)
- 7.4.2 Asia-Pacific Parenteral PrEP Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Parenteral PrEP Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Parenteral PrEP Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Gilead Sciences
- 8.1.1 Gilead Sciences Company Information
- 8.1.2 Gilead Sciences Business Overview
- 8.1.3 Gilead Sciences Parenteral PrEP Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Gilead Sciences Parenteral PrEP Product Portfolio
- 8.1.5 Gilead Sciences Recent Developments
- 8.2 ViiV Healthcare
- 8.2.1 ViiV Healthcare Company Information
- 8.2.2 ViiV Healthcare Business Overview
- 8.2.3 ViiV Healthcare Parenteral PrEP Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 ViiV Healthcare Parenteral PrEP Product Portfolio
- 8.2.5 ViiV Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Parenteral PrEP Value Chain Analysis
- 9.1.1 Parenteral PrEP Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Parenteral PrEP Production Mode & Process
- 9.2 Parenteral PrEP Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Parenteral PrEP Distributors
- 9.2.3 Parenteral PrEP Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst